Literature DB >> 34187390

Risk factors and biofilm formation analyses of hospital-acquired infection of Candida pelliculosa in a neonatal intensive care unit.

Zhijie Zhang1, Yu Cao1, Yanjian Li2, Xufang Chen1, Chen Ding2, Yong Liu3.   

Abstract

BACKGROUND: Candida pelliculosa is an ecological fungal species that can cause infections in immunocompromised individuals. Numerous studies globally have shown that C. pelliculosa infects neonates. An outbreak recently occurred in our neonatal intensive care unit; therefore, we aimed to evaluate the risk factors in this hospital-acquired fungal infection.
METHODS: We performed a case-control study, analysing the potential risk factors for neonatal infections of C. pelliculosa so that infection prevention and control could be implemented in our units. Isolated strains were tested for drug resistance and biofilm formation, important factors for fungal transmission that give rise to hospital-acquired infections.
RESULTS: The use of three or more broad-spectrum antimicrobials or long hospital stays were associated with higher likelihoods of infection with C. pelliculosa. The fungus was not identified on the hands of healthcare workers or in the environment. All fungal isolates were susceptible to anti-fungal medications, and after anti-fungal treatment, all infected patients recovered. Strict infection prevention and control procedures efficiently suppressed infection transmission. Intact adhesin-encoding genes, shown by genome analysis, indicated possible routes for fungal transmission.
CONCLUSIONS: The use of three or more broad-spectrum antimicrobials or a lengthy hospital stay is theoretically associated with the risk of infection with C. pelliculosa. Strains that we isolated are susceptible to anti-fungal medications, and these were eliminated by treating all patients with an antifungal. Transmission is likely via adhesion to the cell surface and biofilm formation.

Entities:  

Keywords:  Antifungal drugs; Biofilm; Candida pelliculosa; Fungemia; Infection control

Year:  2021        PMID: 34187390     DOI: 10.1186/s12879-021-06295-1

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  32 in total

1.  Investigation of a nosocomial outbreak of fungemia caused by Candida pelliculosa (Pichia anomala) in a Korean tertiary care center.

Authors:  Jiwon Jung; Young Sook Moon; Jung A Yoo; Ji-Hun Lim; Joseph Jeong; Jae-Bum Jun
Journal:  J Microbiol Immunol Infect       Date:  2017-06-28       Impact factor: 4.399

2.  Neonatal candidemia: a changing trend.

Authors:  Vandana Sardana; Anita Pandey; Molly Madan; S P Goel; Ashish K Asthana
Journal:  Indian J Pathol Microbiol       Date:  2012 Jan-Mar       Impact factor: 0.740

3.  An outbreak of Pichia anomala fungemia in a Brazilian pediatric intensive care unit.

Authors:  Alessandro Comarú Pasqualotto; Teresa Cristina Teixeira Sukiennik; Luiz Carlos Severo; Cledja Soares de Amorim; Arnaldo Lopes Colombo
Journal:  Infect Control Hosp Epidemiol       Date:  2005-06       Impact factor: 3.254

4.  Reporting an outbreak of Candida pelliculosa fungemia in a neonatal intensive care unit.

Authors:  Hsiao-Chuan Lin; Hsiang-Yu Lin; Bai-Hong Su; Mao-Wang Ho; Cheng-Mao Ho; Ching-Yi Lee; Ming-Hsia Lin; Hsin-Yang Hsieh; Hung-Chih Lin; Tsai-Chung Li; Kao-Pin Hwang; Jang-Jih Lu
Journal:  J Microbiol Immunol Infect       Date:  2012-10-08       Impact factor: 4.399

5.  Sequential chemical and enzymatic pretreatment of palm empty fruit bunches for Candida pelliculosa bioethanol production.

Authors:  Tania Sila Campioni; Carlos Ricardo Soccol; Nelson Libardi Junior; Cristine Rodrigues; Adenise Lorenci Woiciechowski; Luiz Alberto Junior Letti; Luciana Porto de Souza Vandenberghe
Journal:  Biotechnol Appl Biochem       Date:  2019-10-25       Impact factor: 2.431

6.  Function of Candida albicans adhesin Hwp1 in biofilm formation.

Authors:  Clarissa J Nobile; Jeniel E Nett; David R Andes; Aaron P Mitchell
Journal:  Eukaryot Cell       Date:  2006-10

7.  Fungaemia caused by Hansenula anomala--an outbreak in a cancer hospital.

Authors:  L C Thuler; S Faivichenco; E Velasco; C A Martins; C R Nascimento; I A Castilho
Journal:  Mycoses       Date:  1997-10       Impact factor: 4.377

8.  Hansenula anomala outbreak at a surgical intensive care unit: a search for risk factors.

Authors:  S Kalenic; M Jandrlic; V Vegar; N Zuech; A Sekulic; E Mlinaric-Missoni
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

9.  Infection and colonisation of neonates by Hansenula anomala.

Authors:  N Murphy; C R Buchanan; V Damjanovic; R Whitaker; C A Hart; R W Cooke
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

10.  Yeast Identification During Fermentation of Turkish Gemlik Olives.

Authors:  Gamze Mujdeci; María Arévalo-Villena; Z Yesim Ozbas; Ana Briones Pérez
Journal:  J Food Sci       Date:  2018-04-18       Impact factor: 3.167

View more
  2 in total

1.  Thidiazuron, a phenyl-urea cytokinin, inhibits ergosterol synthesis and attenuates biofilm formation of Candida albicans.

Authors:  Pandurangan Harikrishnan; Balamani Arayambath; Vijay Karthik Jayaraman; Kanimozhi Ekambaram; Emad A Ahmed; Palanisamy Senthilkumar; Hairul-Islam Mohamed Ibrahim; Arjunan Sundaresan; Krishnaraj Thirugnanasambantham
Journal:  World J Microbiol Biotechnol       Date:  2022-09-17       Impact factor: 4.253

2.  Update of the list of QPS-recommended microbiological agents intentionally added to food or feed as notified to EFSA 16: suitability of taxonomic units notified to EFSA until March 2022.

Authors:  Kostas Koutsoumanis; Ana Allende; Avelino Alvarez-Ordóñez; Declan Bolton; Sara Bover-Cid; Marianne Chemaly; Robert Davies; Alessandra De Cesare; Friederike Hilbert; Roland Lindqvist; Maarten Nauta; Luisa Peixe; Giuseppe Ru; Marion Simmons; Panagiotis Skandamis; Elisabetta Suffredini; Pier Sandro Cocconcelli; Pablo Salvador Fernández Escámez; Miguel Prieto Maradona; Amparo Querol; Lolke Sijtsma; Juan Evaristo Suarez; Ingvar Sundh; Just Vlak; Fulvio Barizzone; Michaela Hempen; Sandra Correia; Lieve Herman
Journal:  EFSA J       Date:  2022-07-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.